Detalhe da pesquisa
1.
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analyses.
Muscle Nerve
; 66(1): 39-49, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098554
2.
Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS.
Cells
; 12(7)2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37048104
3.
Macrophage-Targeted Sodium Chlorite (NP001) Slows Progression of Amyotrophic Lateral Sclerosis (ALS) through Regulation of Microbial Translocation.
Biomedicines
; 10(11)2022 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428474
4.
Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.
Neurol Neuroimmunol Neuroinflamm
; 2(3): e100, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25884010